Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)

NCT00004306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2012-03-06

No results posted yet for this study

Summary

OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies.

II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.

Conditions

  • Hereditary Ataxia

Sponsors & Collaborators

  • The University of Texas Medical Branch, Galveston

    collaborator OTHER
  • Office of Rare Diseases (ORD)

    lead NIH

Principal Investigators

  • Tetsuo Ashizawa, MD · University of Texas, Galveston

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-11-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004306 on ClinicalTrials.gov